<DOC>
	<DOCNO>NCT01159730</DOCNO>
	<brief_summary>The purpose study assess safety tolerability multiple dose VB-201 administer 4 week efficacy biomarkers .</brief_summary>
	<brief_title>Study Assess Safety Efficacy Multiple Doses VB-201 Biomarkers</brief_title>
	<detailed_description />
	<criteria>Male female patient , ≥18 ≤75 year age ; Presence , history cancer , exception completely excise , nonmetastatic squamous cell basal cell carcinoma skin ; Has clinically significant systemic infection ( e.g. , chronic acute infection , UTI , URI ) within 30 day Day 0 , history presence recurrent chronic infection ( e.g . viral infection , [ include hepatitis B C , HIV ] , bacterial infection , systemic fungal infection , syphilis ) ; Subjects history coronary event within last 6 month ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>